Literature DB >> 25884202

Surgical resections of ulcerative colitis associated with dysplasia or carcinoma.

Shinichi Sameshima1, Shinichiro Koketsu2, Emiko Takeshita3, Yawara Kubota4, Takashi Okuyama5, Kazuyuki Saito6, Yoshihiko Ueda7, Toshio Sawada8, Masatoshi Oya9.   

Abstract

BACKGROUND: Ulcerative colitis (UC) patients have an increased risk of colorectal dysplasia and carcinoma. The purpose of this study was to analyze the clinical features and surgical treatment of ulcerative colitis associated with dysplasia or carcinoma.
METHODS: We operated on 41 UC patients since April 2000. Twelve of the cases were associated with dysplasia or carcinoma. Ten patients were male and two were female; the median age was 58.0 years, and the average duration of disease was 19.2 years. Nine cases were pancolitis type and three were left-sided type. Six cases were remission-relapsing type and six were chronic inflammation type. In 10 of 12 cases, dysplasia or carcinoma was diagnosed before the operations. Nine cases were primary operations and two were second-time operations.
RESULTS: Among ten patients who underwent primary operations, four patients had open surgery and six patients had hand-assisted laparoscopic surgery (HALS). Seven patients received anus/anal sphincter-preserving operations with reconstruction by the ileal pouch technique. Ileal pouch anal-canal anastomosis (IPACA) was performed in five cases and ileal pouch anal anastomosis (IPAA) in two cases. Abdomino-peritoneal resection was performed in two cases, proctcolectomy with permanent ileostomy in one case, and right hemicolectomy in one case. A 39-year-old patient was unresectable due to dissemination of the carcinoma. A 55-year-old patient who underwent IPACA showed night soiling postoperatively. Other patients who received IPAA and IPACA showed favorable anal function postoperatively. Histological examination showed low-grade dysplasia in two cases, high-grade dysplasia in three cases, and adenocarcinoma in seven cases. In the seven cases of adenocarcinoma, four, two, and one cases were stage 1, 3, and 4 according to TNM classification. Three of five cases with dysplasia were detected by surveillance colonoscopy. All patients with carcinoma were symptomatic and did not undergo surveillance colonoscopy.
CONCLUSIONS: IPACA by HALS was safely performed as an anal-preserving operation in UC patients with dysplasia or carcinoma. Non-anal-preserving operations for aged patients showed a preferable postoperative course. Surveillance colonoscopy is essential for detecting dysplasia before the development of carcinoma.

Entities:  

Mesh:

Year:  2015        PMID: 25884202      PMCID: PMC4340839          DOI: 10.1186/s12957-015-0499-4

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


Background

Ulcerative colitis (UC) patients have an increased risk of dysplasia and developing colorectal carcinoma (CRC). Patients with UC have a 2.4-fold increased overall CRC risk [1]. The cumulative probability of UC patients developing CRC is 2% by 10 years, 8% by 20 years, and 18% by 30 years, according to a recent meta-analysis [2]. Chronic inflammation and the increased turnover of epithelial cells contribute to the development of dysplasia which may further transform into CRC [3]. Riddell described two categories of dysplasia associated with UC, indefinite and positive [4]. The indefinite category includes the subcategories probably negative (probably inflammatory), unknown, and probably positive (probably dysplastic). The positive category includes low-grade dysplasia (LGD) and high-grade dysplasia (HGD). Kiran reported that carcinoma was present in 29% of patients with preoperative HGD compared with 3% in those with LGD [5]. Thus, the risk of carcinoma in patients with HGD is substantial. It is therefore important to conduct surveillance colonoscopy to detect dysplasia before CRC develops [6]. The standard surgical procedure for patients with UC is restorative proctocolectomy with construction of a hand-sewn ileal pouch anal anastomosis (IPAA) or an ileal pouch anal-canal anastomosis (IPACA) created with a circular stapler. IPAA totally removes the rectal mucosa and eliminates the risk of future development of carcinoma in the anorectal cuff. However, the IPAA procedure is more complicated and time-consuming compared with IPACA. The preservation of anal function following IPAA, especially in older patients, is the subject of debate and has been scarcely addressed in the scientific literature. It has been reported that IPAA can be safely offered to selected old UC patients who are strongly motivated and who have no clinical disturbances of continence [7]. Al-Sukhni reported that IPACA does not appear to be inferior to IPAA with respect to oncologic outcomes, and it seems appropriate in patients with UC associated with coexisting dysplasia or carcinoma [8]. Laparoscopic procedures have been applied to total proctocolectomy for UC patients. Compared with open surgery, laparoscopic surgery for UC was shown to be at least as safe and was superior with respect to postoperative fasting time, postoperative hospital stay, and overall complication rate, according to the results of a meta-analysis [9]. However, the clinical value of laparoscopic surgery for UC needs further evaluation. Colectomy for UC patients with dysplasia or carcinoma requires sufficient lymph node resections with mobilization of the mesenteries and high ligation of the arteries. Tsuruta reported that hand-assisted laparoscopic surgery (HALS) had a significantly lower operative time compared with conventional laparoscopic proctocolectomy [10]. In the present study, we performed HALS for proctocolectomy of UC patients. Colectomy was performed in 41 UC patients. Dysplasia or carcinoma was observed in 12 cases, and these cases were analyzed clinicohistopathologically.

Methods

A total of 41 UC patients underwent colectomy from April 2000 to December 2013. Nineteen patients were male and twenty two were female. The median age was 41.4 years (range 19 to 73). Histological diagnosis of dysplasia and carcinoma associated with UC was performed according to the criteria described by Riddell [4]. Twelve cases were confirmed to be associated with dysplasia or carcinoma based on histological assessment of resected specimens, and these twelve cases were enrolled in the study. Clinicopathological classifications and stage groupings for carcinoma were performed based on the seventh edition TNM classification of colorectal cancer [11]. Written informed consent was obtained from all patients.

Results

Surgical resection procedures

Ten cases were primary operations (Figure 1), and two cases were second-time operations. In seven of ten primary operations, the anus and anal sphincter were preserved and permanent colostomy was avoided. Five IPACA cases underwent HALS. The average operation time for HALS was 310 min. The average bleeding volume was 350.6 g. In one patient in whom IPACA by HALS was started, IPAA was performed instead due to difficulties with the stapling anastomosis procedure. Two patients received permanent stoma. One 39-year-old female patient with carcinoma was unresectable due to peritoneal dissemination and underwent ileostomy instead.
Figure 1

Surgical procedures for primary resection in ulcerative colitis cases associated with dysplasia or carcinoma. Asterisk indicates the procedure was done by HALS; double asterisk indicates carcinoma was not diagnosed preoperatively. IPAA = ileal pouch anal anastomosis, IPACA = ileal pouch anal-canal anastomosis, HALS = hand-assisted laparoscopic surgery.

Surgical procedures for primary resection in ulcerative colitis cases associated with dysplasia or carcinoma. Asterisk indicates the procedure was done by HALS; double asterisk indicates carcinoma was not diagnosed preoperatively. IPAA = ileal pouch anal anastomosis, IPACA = ileal pouch anal-canal anastomosis, HALS = hand-assisted laparoscopic surgery. In the two patients who had a second operation, the procedures performed were abdomino-peritoneal dissection and left colectomy.

Postoperative complications

A 55-year-old male patient who received IPAA showed soiling in the nighttime after ileostomy closure. This led the patient to use a pad while sleeping. A 73-year-old male patient who underwent abdomino-peritoneal resection and transverse colostomy showed prolapse of the stoma 3 months after the original operation. The stoma was subsequently reconstructed.

Histology

Twelve cases were confirmed to be associated with dysplasia or carcinoma based on histology of the resected specimen. The characteristics of these 12 patients are presented in Table 1. Dysplasia or carcinoma was diagnosed preoperatively in 9 of the 12 cases. Two patients who had a colectomy due to steroid-dependent UC were not diagnosed with dysplasia preoperatively. However, histological examination demonstrated dysplasia in the resected specimen postoperatively. Patients who were diagnosed with dysplasia or carcinoma preoperatively were detected by colonoscopy. Three patients who were diagnosed with dysplasia preoperatively were followed-up by surveillance colonoscopy, while patients with carcinoma did not undergo surveillance colonoscopy (Table 2).
Table 1

Characteristics of ulcerative colitis cases associated with dysplasia or carcinoma

Characteristics
No. of patients12
Male/female10/2
Age (years), median (range)58.0 (28 to 73)
Average duration of disease (years), median (range)19.2 (12 to 30)
Site of inflammation
 Pan colitis9
 Left-sided colitis3
Inflammation type
 Remission-relapsing6
 Chronic inflammation6
Operation
 Primary operation10
 Reoperation2
Laparoscopic surgery
 Open surgery6
 HALS6
Preoperative diagnosis of dysplasia or carcinoma
 Yes10
 No2

HALS hand-assisted laparoscopic surgery.

Table 2

Reasons for surgical resection in UC cases associated with dysplasia or carcinoma

Dysplasia ( n = 5) Carcinoma ( n = 7)
Steroid dependent20
Stenosis01
Preoperative diagnosis of dysplasia or carcinoma by colonoscopy36
Characteristics of ulcerative colitis cases associated with dysplasia or carcinoma HALS hand-assisted laparoscopic surgery. Reasons for surgical resection in UC cases associated with dysplasia or carcinoma The grade of dysplasia and TNM staging of carcinomas are presented in Table 3. Eight patients showed single lesion of dysplasia or carcinoma in the resected specimen. Two patients with low-grade or high-grade dysplasia showed double lesions of dysplasia in the resected specimens. Two patients with stage II or III carcinoma showed triple carcinomas in the resected specimens.
Table 3

Grade of dysplasia and TNM staging of carcinoma

TNM Histological type No. of patients with single lesion No. of patients with multiple lesions
Low-grade dysplasia11
High-grade dysplasia21
pT1N0M0Well-differentiated adenocarcinoma30
pT2N0M0Well-differentiated adenocarcinoma01
pT3N1M0Well-differentiated adenocarcinoma11
sT4NXM1Well-differentiated adenocarcinoma10
84
Grade of dysplasia and TNM staging of carcinoma

Discussion

We performed colectomies in 12 UC patients with dysplasia or carcinoma. In six patients, proctocolectomy was performed by HALS, which was associated with a shorter operation time compared with conventional laparoscopic proctocolectomy. Although HALS is a useful procedure, the length of incision is longer than that with conventional laparoscopic surgery. Recently, we began performing pure laparoscopic proctocolectomy without lymph node resection for UC patients who do not have a preoperative diagnosis of dysplasia or carcinoma. We performed IPACA mainly for reconstruction after proctocolectomy because the IPAA procedure is more complicated and time-consuming than IPACA. A 55-year-old patient who received IPAA showed night soiling after the operation. With respect to preservation of anal function, IPAA may not be suitable for patients older than middle age. IPACA also carries the risk of carcinoma in the remnant rectal mucosa. The risk is quite small, however, and colonoscopy surveillance should be performed to monitor the remaining rectal mucosa. The number of UC patients is increasing in Japan as well as in Western countries, and the number of UC patients with a long duration of disease is also rising. When UC patients reach middle age, the risk of dysplasia and carcinoma increases. The rate of dysplasia or carcinoma among operated UC patients is increasing in our hospital (data not shown), which is a disturbing trend. Surveillance colonoscopy for dysplasia and carcinoma is recommended for patients with long-standing UC. Patients in whom dysplasia or carcinoma is detected by surveillance colonoscopy show a better prognosis, while those who do not undergo surveillance often develop advanced carcinoma and have a poor prognosis [12]. We performed colectomy in a total of 41 UC patients; 12 patients showed dysplasia or carcinoma, and 3 of 5 dysplasia cases in patients were detected by surveillance colonoscopy. None of the patients with carcinoma underwent surveillance colonoscopy. These patients, upon presentation of symptoms, underwent colonoscopy, which underscores the importance of surveillance colonoscopy. Two patients who had colectomies due to steroid-dependent UC were not diagnosed with dysplasia preoperatively but were diagnosed based on analysis of resected specimens postoperatively. In such cases, endoscopic detection of dysplasia might be difficult because of mucosal inflammation. It is reported that CRC-associated UC showed multiple lesions (11%) [13]. In our study, two of seven patients with carcinoma showed the triple carcinoma lesions. Advanced carcinoma affects the lifespan of UC patients. In a study conducted in Japan, Watanabe reported that patients with CRC-associated UC showed poorer survival rates than those with sporadic CRC in the advanced stage, while no difference was observed in the early stage [13]. It is important to detect dysplasia and carcinoma in an early stage by surveillance, and surveillance colonoscopy for UC patients with long disease duration is essential.

Conclusions

IPACA by HALS was safely performed as an anal-preserving operation in UC patients with dysplasia or carcinoma. Non-anal-preserving operations for aged patients showed a preferable postoperative course. Surveillance colonoscopy for UC patients with long disease duration is essential for detecting dysplasia before the development of carcinoma.
  12 in total

1.  Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies.

Authors:  Tine Jess; Christine Rungoe; Laurent Peyrin-Biroulet
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-28       Impact factor: 11.382

Review 2.  The role of laparoscopic surgery for ulcerative colitis: systematic review with meta-analysis.

Authors:  Xiao-Jian Wu; Xiao-Sheng He; Xu-Yu Zhou; Jia Ke; Ping Lan
Journal:  Int J Colorectal Dis       Date:  2010-02-17       Impact factor: 2.571

3.  Clinicopathological features of ulcerative colitis-associated colorectal cancer pointing to efficiency of surveillance colonoscopy in a large retrospective Japanese cohort.

Authors:  Hiroki Matsuoka; Hiroki Ikeuchi; Motoi Uchino; Toshihiro Bando; Yoshio Takesue; Takayuki Nishigami; Naohiro Tomita
Journal:  Int J Colorectal Dis       Date:  2012-10-19       Impact factor: 2.571

4.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

5.  Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study.

Authors:  Toshiaki Watanabe; Tsuyoshi Konishi; Junji Kishimoto; Kenjiro Kotake; Tetsuichiro Muto; Kenichi Sugihara
Journal:  Inflamm Bowel Dis       Date:  2011-03       Impact factor: 5.325

6.  Oncologic outcome in patients with ulcerative colitis associated with dyplasia or cancer who underwent stapled or handsewn ileal pouch-anal anastomosis.

Authors:  Wigdan Al-Sukhni; Robin S McLeod; Helen MacRae; Brenda O'Connor; Harden Huang; Zane Cohen
Journal:  Dis Colon Rectum       Date:  2010-11       Impact factor: 4.585

7.  Hand-assisted versus conventional laparoscopic restorative proctocolectomy for ulcerative colitis.

Authors:  Masashi Tsuruta; Hirotoshi Hasegawa; Yoshiyuki Ishii; Takashi Endo; Hiroki Ochiai; Toshifumi Hibi; Yuko Kitagawa
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2009-02       Impact factor: 1.719

Review 8.  Strategies for detecting colon cancer and dysplasia in patients with inflammatory bowel disease.

Authors:  Paul D Collins
Journal:  Inflamm Bowel Dis       Date:  2013 Mar-Apr       Impact factor: 5.325

9.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

Authors:  R H Riddell; H Goldman; D F Ransohoff; H D Appelman; C M Fenoglio; R C Haggitt; C Ahren; P Correa; S R Hamilton; B C Morson
Journal:  Hum Pathol       Date:  1983-11       Impact factor: 3.466

10.  Complications and functional outcomes of restorative proctocolectomy for ulcerative colitis in the elderly.

Authors:  Gianluca Pellino; Guido Sciaudone; Giuseppe Candilio; Antonio Camerlingo; Rosa Marcellinaro; Federica Rocco; Serena De Fatico; Silvestro Canonico; Francesco Selvaggi
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

View more
  3 in total

Review 1.  Endoscopic detection and resection of dysplasia in inflammatory bowel disease-techniques with videos.

Authors:  Sameen Khalid; Aamer Abbass; Neelam Khetpal; Bo Shen; Udayakumar Navaneethan
Journal:  Int J Colorectal Dis       Date:  2019-03-11       Impact factor: 2.571

2.  Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis.

Authors:  Jianxia Hu; Gang Zhao; Lize Zhang; Cuixia Qiao; Aiping Di; Hong Gao; Hong Xu
Journal:  Exp Ther Med       Date:  2016-09-20       Impact factor: 2.447

3.  Ulcerative colitis associated with nephrotic syndrome after treatment with mesalazine developed into rectal carcinoma: a case study.

Authors:  Shinichi Sameshima; Shinichiro Koketsu; Takashi Okuyama; Yawara Kubota; Yuko Ono; Tamaki Noie; Masatoshi Oya
Journal:  World J Surg Oncol       Date:  2016-07-22       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.